Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans

Overview of attention for article published in Frontiers in endocrinology, August 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,547 followers.

New NUTRITION Research Available. Click Here to Access Article(s): https://t.co/LiU3hoJhnY

RT @FrontEndocrinol: New Research: Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to human…

RT @FrontEndocrinol: New Research: Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to human…

New Research: Editorial: FGF21 as a therapeutic target for obesity and insulin resistance: from rodent models to humans #Endocrinology #Endo https://t.co/X2TxgFCqAr

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.